Mechanism of isoflurane‑mediated breast cancer growth <em>in vivo</em>

Koutsogiannaki,Sophia; Wang,Wei; Hou,Lifei; Okuno,Toshiaki; Yuki,Koichi

doi:10.3892/ol.2024.14420

Mechanism of isoflurane‑mediated breast cancer growth in vivo

Authors:
- Sophia Koutsogiannaki
- Wei Wang
- Lifei Hou
- Toshiaki Okuno
- Koichi Yuki
View Affiliations

Affiliations: Department of Anesthesiology, Critical Care and Pain Medicine, Cardiac Anesthesia Division, Boston Children's Hospital, MA 02115, USA, Department of Biochemistry, Juntendo University Faculty of Medicine, Tokyo 113‑8421, Japan
Published online on: April 30, 2024 https://doi.org/10.3892/ol.2024.14420
Article Number: 287

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Use of volatile anesthetics is associated with worse outcome following tumor resection surgery compared with the use of intravenous anesthetics. However, the underlying mechanism has not been clearly delineated yet in vivo. The EO771 cell‑based congenic breast cancer model was used in the present study. Isoflurane directly binds to and inhibits two adhesion molecules, leukocyte function‑associated antigen‑1 (LFA‑1) and macrophage‑1 antigen (Mac‑1). Similarly, exposure to sevoflurane, another volatile anesthetic and LFA‑1 inhibitor, is associated with an increase in breast cancer size compared with non‑exposure. Thus, the present study first examined the role of LFA‑1 and Mac‑1 in the EO771 breast cancer model. Both LFA‑1 deficiency and inhibition enhanced tumor growth, which was supported by cytokine and eicosanoid data profiles. By contrast, Mac‑1 deficiency did not affect tumor growth. The exposure to isoflurane and sevoflurane was associated with an increase in breast cancer size compared with non‑exposure. These data suggested that isoflurane enhanced tumor growth by interacting with LFA‑1. Isoflurane exposure did not affect tumor growth in LFA‑1‑deficient mice. In summary, the present data showed that LFA‑1 deficiency facilitated breast cancer growth, and isoflurane, an LFA‑1 inhibitor, also increased breast cancer growth.

View Figures

View References

1	Wigmore TJ, Mohammed K and Jhanji S: Long-term survival for patients undergoing volatile versus IV anesthesia for cancer surgery: A retrospective analysis. Anesthesiology. 124:69–79. 2016. View Article : Google Scholar : PubMed/NCBI
2	Jun IJ, Jo JY, Kim JI, Chin JH, Kim WJ, Kim HR, Lee EH and Choi IC: Impact of anesthetic agents on overall and recurrence-free survival in patients undergoing esophageal cancer surgery: A retrospective observational study. Sci Rep. 7:140202017. View Article : Google Scholar : PubMed/NCBI
3	Wu ZF, Lee MS, Wong CS, Lu CH, Huang YS, Lin KT, Lou YS, Lin C, Chang YC and Lai HC: Propofol-based total intravenous anesthesia is associated with better survival than desflurane anesthesia in colon cancer surgery. Anesthesiology. 129:932–941. 2018. View Article : Google Scholar : PubMed/NCBI
4	Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A and Bray F: Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 144:1941–1953. 2019. View Article : Google Scholar : PubMed/NCBI
5	Sakamoto K, Schmidt JW and Wagner KU: Mouse models of breast cancer. Methods Mol Biol. 1267:47–71. 2015. View Article : Google Scholar : PubMed/NCBI
6	Casey AE, Laster WR Jr and Ross GL: Sustained enhanced growth of carcinoma EO771 in C57 black mice. Proc Soc Exp Biol Med. 77:358–362. 1951. View Article : Google Scholar : PubMed/NCBI
7	Johnstone CN, Smith YE, Cao Y, Burrows AD, Cross RS, Ling X, Redvers RP, Doherty JP, Eckhardt BL, Natoli AL, et al: Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer. Dis Model Mech. 8:237–251. 2015.PubMed/NCBI
8	Stollings LM, Jia LJ, Tang P, Dou H, Lu B and Xu Y: Immune modulation by volatile anesthetics. Anesthesiology. 125:399–411. 2016. View Article : Google Scholar : PubMed/NCBI
9	Yuki K and Eckenhoff RG: Mechanisms of the immunological effects of volatile anesthetics: A review. Anesth Analg. 123:326–335. 2016. View Article : Google Scholar : PubMed/NCBI
10	Yuki K, Astrof NS, Bracken C, Soriano SG and Shimaoka M: Sevoflurane binds and allosterically blocks integrin lymphocyte function-associated antigen-1. Anesthesiology. 113:600–609. 2010. View Article : Google Scholar : PubMed/NCBI
11	Yuki K, Astrof NS, Bracken C, Yoo R, Silkworth W, Soriano SG and Shimaoka M: The volatile anesthetic isoflurane perturbs conformational activation of integrin LFA-1 by binding to the allosteric regulatory cavity. FASEB J. 22:4109–4116. 2008. View Article : Google Scholar : PubMed/NCBI
12	Yuki K, Bu W, Xi J, Sen M, Shimaoka M and Eckenhoff RG: Isoflurane binds and stabilizes a closed conformation of the leukocyte function-associated antigen-1. FASEB J. 26:4408–4417. 2012. View Article : Google Scholar : PubMed/NCBI
13	Jung S and Yuki K: Differential effects of volatile anesthetics on leukocyte integrin macrophage-1 antigen. J Immunotoxicol. 13:148–156. 2016. View Article : Google Scholar : PubMed/NCBI
14	Shimaoka M and Springer TA: Therapeutic antagonists and conformational regulation of integrin function. Nat Rev Drug Discov. 2:703–716. 2003. View Article : Google Scholar : PubMed/NCBI
15	Ho MK and Springer TA: Mac-1 antigen: quantitative expression in macrophage populations and tissues, and immunofluorescent localization in spleen. J Immunol. 128:2281–2286. 1982. View Article : Google Scholar : PubMed/NCBI
16	Ding ZM, Babensee JE, Simon SI, Lu H, Perrard JL, Bullard DC, Dai XY, Bromley SK, Dustin ML, Entman ML, et al: Relative contribution of LFA-1 and Mac-1 to neutrophil adhesion and migration. J Immunol. 163:5029–5038. 1999. View Article : Google Scholar : PubMed/NCBI
17	Coxon A, Rieu P, Barkalow FJ, Askari S, Sharpe AH, von Andrian UH, Arnaout MA and Mayadas TN: A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: A homeostatic mechanism in inflammation. Immunity. 5:653–666. 1996. View Article : Google Scholar : PubMed/NCBI
18	Berrueta L, Bergholz J, Munoz D, Muskaj I, Badger GJ, Shukla A, Kim HJ, Zhao JJ and Langevin HM: Stretching reduces tumor growth in a mouse breast cancer model. Sci Rep. 8:78642018. View Article : Google Scholar : PubMed/NCBI
19	Tomayko MM and Reynolds CP: Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol. 24:148–154. 1989. View Article : Google Scholar : PubMed/NCBI
20	Sonner JM, Gong D, Li J, Eger EI II and Laster MJ: Mouse strain modestly influences minimum alveolar anesthetic concentration and convulsivity of inhaled compounds. Anesth Analg. 89:1030–1034. 1999. View Article : Google Scholar : PubMed/NCBI
21	Dahan A, Sarton E, Teppema L, Olievier C, Nieuwenhuijs D, Matthes HW and Kieffer BL: Anesthetic potency and influence of morphine and sevoflurane on respiration in mu-opioid receptor knockout mice. Anesthesiology. 94:824–832. 2001. View Article : Google Scholar : PubMed/NCBI
22	Okuno T, Koutsogiannaki S, Hou L, Bu W, Ohto U, Eckenhoff RG, Yokomizo T and Yuki K: Volatile anesthetics isoflurane and sevoflurane directly target and attenuate Toll-like receptor 4 system. FASEB J. 33:14528–14541. 2019. View Article : Google Scholar : PubMed/NCBI
23	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
24	Zha H, Matsunami E, Blazon-Brown N, Koutsogiannaki S, Hou L, Bu W, Babazada H, Odegard KC, Liu R, Eckenhoff RG and Yuki K: Volatile anesthetics affect macrophage phagocytosis. PLoS One. 14:e02161632019. View Article : Google Scholar : PubMed/NCBI
25	Yuki K, Bu W, Shimaoka M and Eckenhoff R: Volatile anesthetics, not intravenous anesthetic propofol bind to and attenuate the activation of platelet receptor integrin αIIbβ3. PLoS One. 8:e604152013. View Article : Google Scholar : PubMed/NCBI
26	Walker OL, Dahn ML, Power Coombs MR and Marcato P: The prostaglandin E2 pathway and breast cancer stem cells: Evidence of increased signaling and potential targeting. Front Oncol. 11:7916962022. View Article : Google Scholar : PubMed/NCBI
27	Akaydin S, Ramazanoğlu S, Salihoğlu EM, Karanlik H and Demokan S: Leukotriene D4 levels in patients with breast cancer. FABAD J Pharm Sci. 47:331–338. 2022.
28	Yuki K: The role of general anesthetic drug selection in cancer outcome. Biomed Res Int. 2021:25630932021. View Article : Google Scholar : PubMed/NCBI
29	Koutsogiannaki S, Schaefers MM, Okuno T, Ohba M, Yokomizo T, Priebe GP, DiNardo JA, Sulpicio SG and Yuki K: From the cover: Prolonged exposure to volatile anesthetic isoflurane worsens the outcome of polymicrobial abdominal sepsis. Toxicol Sci. 156:402–411. 2017.PubMed/NCBI
30	Tazawa K, Koutsogiannaki S, Chamberlain M and Yuki K: The effect of different anesthetics on tumor cytotoxicity by natural killer cells. Toxicol Lett. 266:23–31. 2017. View Article : Google Scholar : PubMed/NCBI
31	Barber DF, Faure M and Long EO: LFA-1 contributes an early signal for NK cell cytotoxicity. J Immunol. 173:3653–3659. 2004. View Article : Google Scholar : PubMed/NCBI
32	Gao N, Wang C, Yu Y, Xie L, Xing Y, Zhang Y, Wang Y, Wu J and Cai Y: LFA-1/ICAM-1 promotes NK cell cytotoxicity associated with the pathogenesis of ocular toxoplasmosis in murine model. PLoS Negl Trop Dis. 16:e00108482022. View Article : Google Scholar : PubMed/NCBI
33	Hickman A, Koetsier J, Kurtanich T, Nielsen MC, Winn G, Wang Y, Bentebibel SE, Shi L, Punt S, Williams L, et al: LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockade. J Clin Invest. 132:e1541522022. View Article : Google Scholar : PubMed/NCBI
34	Hedrick CC and Malanchi I: Neutrophils in cancer: Heterogeneous and multifaceted. Nat Rev Immunol. 22:173–187. 2022. View Article : Google Scholar : PubMed/NCBI
35	DeNardo DG and Ruffell B: Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol. 19:369–382. 2019. View Article : Google Scholar : PubMed/NCBI
36	Tai LH, Tanese de Souza C, Sahi S, Zhang J, Alkayyal AA, Ananth AA and Auer RA: A mouse tumor model of surgical stress to explore the mechanisms of postoperative immunosuppression and evaluate novel perioperative immunotherapies. J Vis Exp. 512532014.PubMed/NCBI
37	Guo P, Huang J, Wang L, Jia D, Yang J, Dillon DA, Zurakowski D, Mao H, Moses MA and Auguste DT: ICAM-1 as a molecular target for triple negative breast cancer. Proc Natl Acad Sci USA. 111:14710–14715. 2014. View Article : Google Scholar : PubMed/NCBI